市场调查报告书
商品编码
1403432
2030 年预充式註射器市场预测:按类型、材料、设计、配销通路、应用和地区进行的全球分析Prefilled Syringes Market Forecasts to 2030 - Global Analysis By Type, By Material, Design, Distribution Channel, Application and By Geography |
根据 Stratistics MRC 的数据,2023 年全球预充式註射器市场规模为 81.5 亿美元,预计在预测期内将以 12.9% 的复合年增长率成长,到 2030 年达到 190.5 亿美元。
预充式註射器是即用型医疗设备,含有预先量好的药物,经过密封和消毒,用于一次性注射。它由筒体、柱塞、针头组成,给药方便、准确、安全。透过降低给药错误和污染的风险并简化医疗程序,预充式註射器可以满足从疫苗和生技药品到慢性病管理和紧急护理等各种治疗中的不同医疗需求。
日内瓦协会发布的报告估计,在过去二十年中,全球医疗保健支出占 GDP 的比例已从约 8% 增加到近 10%,每年估计达 8 兆美元。
慢性病增加
糖尿病、自体免疫疾病和各种神经系统疾病等慢性病发病率的上升正在推动预充式註射器市场的发展。这些疾病需要定期和精确的剂量,增加了对使用者友好和准确的药物传输系统(如预充式註射器)的需求。预充式註射器方便、给药准确,并降低了污染和给药错误的风险,满足了需要频繁给药的患者的需求。此外,慢性病盛行率的上升正促使医疗保健提供者越来越多地选择高效、随时给药的解决方案来加强患者护理和这些疾病的管理,市场的成长轨迹凸显。
注射量限制
虽然这些注射器为许多药物提供了方便和精确的给药,但它们通常具有固定或有限的注射量。这种限制影响某些需要大给药或给药变化的药物。对于超出註射器容量的药物,必须考虑替代的输送系统,限制了预充式註射器对所有类型药物的普遍适用性。这种适应不同给药要求的限制限制了预充式註射器在某些治疗领域的普及,并影响了市场渗透率。
扩大新兴市场的医疗保健基础设施
新兴市场医疗保健基础设施的扩张为预充式註射器市场带来了巨大的机会。这些地区的医疗保健设施显着增加,增加了对高效且具成本效益的药物输送系统的需求。此外,在资源有限的环境中简化给药和储存的潜力增加了其吸引力,推动了新兴经济体快速成长的医疗基础设施的采用和市场扩张。
严格的监管要求和核准流程
严格的监管要求和核准流程对预充式註射器市场构成重大威胁。需要遵守复杂的监管标准,特别是在材料相容性、製造标准和无菌保证方面,延长了产品开发和市场进入所需的时间和资源。合规性挑战可能会导致核准延迟、开发成本增加和创新受限。这些严格的法规为新进入者设置了障碍,影响市场竞争力并阻碍市场成长。
COVID-19 大流行对预充式註射器市场产生了重大影响。随着世界各地疫苗接种宣传活动变得紧迫,对有效给药疫苗的预充式註射器的需求不断增加。製造商面临增加产量以满足全球疫苗分销要求的挑战,导致供应链挑战和原材料竞争加剧。此外,严格的安全措施、监管调整以及对大规模疫苗接种宣传活动的关注正在加速预充式註射器技术的创新和投资,以确保安全、高效和可扩展的疫苗输送解决方案。我做到了。
预计玻璃领域在预测期内将成为最大的领域
在预充式註射器中,玻璃部分预计将占据最大的市场占有率。玻璃具有化学惰性等卓越品质,可确保稳定性以及与多种药物的相容性。其透明度有利于目视检查,这对于药物完整性至关重要。随着对生技药品和敏感药品的需求不断增加,玻璃的防潮和气体阻隔性能成为首选。此外,对药物交互作用的日益担忧以及对精确药物输送的需求正在推动人们对玻璃的偏好,从而巩固了其在预充式註射器市场的主导地位。
网路商店领域预计在预测期内复合年增长率最高
由于医疗保健领域电子商务的崛起趋势,网路商店领域预计将在预充式註射器市场中呈现最高成长率。线上平台为消费者提供便利、可近性和广泛的产品。随着数位平台的日益普及,患者和医疗保健提供者更喜欢线上订购医疗用品的便利性。随着世界向数位化的转变以及对非接触式交易的日益重视,预计预灌封注射器市场的网路商店将快速成长。
由于其强大的医疗基础设施、对先进医疗技术的高度认识以及对注射药物需求的快速增长,北美预计将占据预充式註射器市场的最大份额。该地区拥有成熟的製药业,加上在研发方面的大量投资,使其成为预充式註射器的主要市场。此外,对以患者为中心的药物输送的日益关注进一步推动了预充式註射器的采用,有助于巩固北美市场的主导地位。
亚太地区预充式註射器市场的强劲成长归因于该地区医疗基础设施的不断扩大、药品投资的增加以及对患者安全的日益重视。不断增长的医疗保健支出、庞大的患者群体以及政府推广先进医疗保健技术的倡议正在推动对预充式註射器的需求。此外,该地区的免疫计划,加上慢性病的迅速增加,正在推动预充式註射器的采用。
According to Stratistics MRC, the Global Prefilled Syringes Market is accounted for $8.15 billion in 2023 and is expected to reach $19.05 billion by 2030 growing at a CAGR of 12.9% during the forecast period. Prefilled syringes are ready-to-use medical devices containing a premeasured dose of medication, sealed and sterilized for single-use injection. Comprising a barrel, plunger and needle, they offer convenience, accuracy, and safety in drug administration. Prefilled syringes reduce dosing errors, contamination risks and streamline medical procedures, catering to diverse healthcare needs across various treatments, from vaccines and biologics to chronic disease management and emergency medicine.
According to a report published by Geneva Association, in the last two decades, the share of total aggregate global expenditure on healthcare in GDP has increased from about 8% to almost 10%, or an estimated USD 8 trillion per annum.
The escalating incidence of chronic illnesses, such as diabetes, autoimmune disorders, and various neurological conditions, has propelled the prefilled syringes market. These conditions require regular and precise medication dosages, fostering the demand for user-friendly, accurate drug delivery systems like prefilled syringes. Offering convenience, dosage accuracy and reduced risks of contamination or dosage errors, prefilled syringes address the needs of patients requiring frequent medication. Additionally, this rising prevalence of chronic diseases emphasizes the market's growth trajectory as healthcare providers increasingly opt for efficient, ready-to-administer solutions to enhance patient care and management of these conditions.
These syringes offer convenience and accurate dosing for many medications, they often come with fixed or limited injection volumes. This constraint affects certain drugs requiring larger doses or those with variable dosage needs. For medications that exceed the syringe's volume capacity, alternative delivery systems must be considered, limiting the universal applicability of prefilled syringes across all medication types. This limitation in accommodating diverse dosage requirements restrains their widespread adoption in certain therapeutic areas, impacting their market penetration.
The expanding healthcare infrastructure in emerging markets presents a significant opportunity for the prefilled syringes market. As these regions witness substantial growth in medical facilities, there's a heightened demand for efficient and cost-effective drug delivery systems. Additionally, their potential for streamlined administration and storage in resource-limited settings enhances their attractiveness, driving their adoption and market expansion within burgeoning healthcare infrastructures across emerging economies.
Stringent regulatory requirements and approval processes pose a significant threat to the prefilled syringes market. The need to adhere to complex regulatory standards, especially regarding material compatibility, manufacturing standards and sterility assurance, prolongs the time and resources required for product development and market entry. Compliance challenges may lead to delays in approvals, increasing development costs and potentially limiting innovation. These rigorous regulations create barriers for new entrants, impacting market competitiveness and hindering market growth.
The COVID-19 pandemic significantly impacted the prefilled syringes market. The urgent need for vaccination campaigns worldwide propelled demand for prefilled syringes to administer vaccines efficiently. Manufacturers faced increased production to meet global vaccine distribution requirements, leading to supply chain challenges and heightened competition for materials. Additionally, stringent safety measures, regulatory adaptations and the focus on mass vaccination campaigns accelerated innovation and investment in prefilled syringe technologies to ensure safe, efficient and scalable vaccine delivery solutions.
The glass segment is anticipated to secure the largest market share in prefilled syringes. Glass offers superior qualities such as chemical inertness, ensuring stability and compatibility with a wide range of medications. Its transparency enables easy visual inspection, which is crucial for drug integrity. With an increasing demand for biologics and sensitive formulations, glass's barrier properties against moisture and gases are preferred. Moreover, heightened concerns about drug interaction and the need for precise drug delivery amplify the preference for glass, solidifying its dominance in the prefilled syringes market.
The online store segment is expected to witness the highest growth rate in the prefilled syringes market due to the increasing trend of e-commerce in healthcare. Online platforms provide convenience, accessibility, and a wide product range for consumers. With the rising adoption of digital platforms, patients and healthcare providers prefer the ease of ordering medical supplies online. The ongoing global shift towards digitalization and emphasizing contactless transactions further drives the anticipated rapid growth of online stores in the prefilled syringes market.
North America is poised to secure the largest market share in prefilled syringes due to a robust healthcare infrastructure, high awareness of advanced medical technologies, and a surge in demand for injectable drugs. The region's well-established pharmaceutical industry, coupled with significant investments in research and development, positions it as a key market for prefilled syringes. Additionally, increased focus on patient-centric drug delivery further fuels the adoption of prefilled syringes, contributing to North America's dominant position in the market.
Asia Pacific's robust growth in the prefilled syringes market is attributed to the region's expanding healthcare infrastructure, rising investments in pharmaceuticals and a growing emphasis on patient safety. Increasing healthcare expenditure, a large patient population and government initiatives promoting advanced healthcare technologies drive the demand for prefilled syringes. Moreover, the region's escalating vaccination programs, coupled with the burgeoning prevalence of chronic diseases, bolster the adoption of prefilled syringes.
Some of the key players in prefilled syringes market include BD (Becton, Dickinson and Company), Catalent, Daikyo Seiko, Ltd., Gerresheimer, Haselmeier GmbH, Nemera, Nipro Corporation, Recipharm, SCHOTT AG, SHL Group, Stevanato Group, Terumo Corporation, Vaccinex, Inc., Vetter Pharma International GmbH, Weigao Group, West Pharmaceutical Services, Inc., Wuxi AppTec and Ypsomed.
In July 2023, KORU Medical Systems announced the 510(K) Submission for Freedom60® Infusion System with Hizentra® 50 mL Prefilled Syringes.
In May 2023, Nexus Pharmaceuticals announced the FDA approval of single-dose prefilled syringes for Emerphed® (ephedrine sulfate injection) used for the treatment of clinically important hypotension occurring in the setting of anesthesia.
In January 2022, Owen Mumford announced that it received approval for its UniSafe 1mL safety device for pre-filled syringes in Asia. In Europe, regulatory approval has also been granted for UniSafe 1mL, and the product is now available on the market as a combination product with a drug for the treatment of rheumatoid arthritis.